Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: Analysis of early outcome data

Title: Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: Analysis of early outcome data
Authors: Townend, P; de Reuver, PR; Chua, TC; Mittal, A; Clark, SJ; Pavlakis, N; Gill, AJ; Samra, JS
Publisher Information: John Wiley & Sons
Publication Year: 2018
Collection: Griffith University: Griffith Research Online
Subject Terms: Clinical sciences; lymph node; metastasis; neoadjuvant chemotherapy; pancreatic cancer; pancreatoduodenectomy
Description: Background: Neoadjuvant therapy is increasingly recognized as an effective strategy prior to pancreatoduodenectomy. We investigate the role of neoadjuvant chemotherapy (NAC) followed by surgery and the predictive role of viable residual tumour cells histopathologically on outcomes. Methods: The study population comprised of 195 consecutive patients with pancreatic adenocarcinoma who were treated with either NAC or a surgery-first (SF) strategy. Histopathological viable tumour cells were examined in the NAC patients and clinicopathological factors were correlated with overall survival. Results: Forty-two patients (22%) were treated with NAC and 153 patients (78%) underwent SF. NAC was associated with higher estimated blood loss during surgery (928 mL versus 615 mL; P = 0.004), fewer (65% residual tumour cells was 45% and 90% in patients who had
Document Type: article in journal/newspaper
Language: English
Relation: ANZ Journal of Surgery; Townend, P; de Reuver, PR; Chua, TC; Mittal, A; Clark, SJ; Pavlakis, N; Gill, AJ; Samra, JS, Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: Analysis of early outcome data, ANZ Journal of Surgery, 2018, 88 (3), pp. E167-E172; https://hdl.handle.net/10072/406276
DOI: 10.1111/ans.13897
Availability: https://hdl.handle.net/10072/406276; https://doi.org/10.1111/ans.13897
Rights: open access
Accession Number: edsbas.6F7A117A
Database: BASE